Dr. Arvind C. Reddy, MD

Dr. Reddy practices at Texas Gastro Consultants, P.a. in Tomball, Texas.

Dr. Reddy's NPI, 1366557886, was assigned on August 21, 2006. Dr. Reddy graduated from Kasturba Medical College Manipal in 2001. Dr. Reddy's Texas license number on file is N4693.

Dr. Reddy's primary practice is Texas Gastro Consultants, P.a., at 506 Graham Dr Suite 100 Suite 100, Tomball, TX 77375-3348. The practice phone is (281) 351-6464.

Dr. Reddy's primary practice is Texas Gastro Consultants, P.a. in Tomball, Texas. Dr. Reddy is also affiliated with HCA Houston Healthcare Tomball. The medical group on file is Texas Gastro Consultants. Dmand AI also links Dr. Reddy to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Reddy is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Reddy's licenses on file in 3 states: Texas, Michigan and Minnesota.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Reddy treats.

CMS data shows 2,265 Medicare services from Dr. Reddy across 21 procedure codes in 2024, for 963 Medicare patients. Medicare paid $232,810 for them.

CMS counts 963 Medicare patients who saw Dr. Reddy in 2024. The largest group is 65 to 74, with 539 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 70, with 61% women.

In 2024, Dr. Reddy wrote 2,881 Medicare Part D claims for 893 patients. 88% of them were for generic drugs. CMS names the drug for 2,647 of them, across 32 drugs with 11 or more claims each, at $294,473 in total drug cost. In 2023, CMS named 2,382 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Reddy for performance year 2024, reported as part of a group. Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth. CMS counts 240 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Reddy, more than 93% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Reddy, published from 2006 to 2013. The most frequent topics are Carcinoma, Hepatocellular and Liver Neoplasms. Dr. Reddy's most frequent co-authors are Murray Norman Ehrinpreis, MD, Elizabeth J. May, MD, PhD and Milton G. Mutchnick, MD.

CMS Open Payments shows 168 general payments to Dr. Reddy from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,284.

Dr. Reddy graduated from Kasturba Medical College Manipal in 2001. Dr. Reddy is a member of ACG and ASGE.

Dr. Reddy is in network with 21 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.